title: [Soft tissue tumors: indications and results of hyperthermia].
authors.affiliation: Institut für klinische Hämatologie (GSF), Grosshadern.
authors.forename: R D
authors.initials: RD
authors.lastname: Issels
authors.forename: D
authors.initials: D
authors.lastname: Bosse
authors.forename: M
authors.initials: M
authors.lastname: Starck
authors.forename: S
authors.initials: S
authors.lastname: Abdel-Rahman
authors.forename: K W
authors.initials: KW
authors.lastname: Jauch
authors.forename: F W
authors.initials: FW
authors.lastname: Schildberg
authors.forename: W
authors.initials: W
authors.lastname: Wilmanns
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006979:Hyperthermia, Induced; D007069:Ifosfamide / Q000008:administration & dosage; D008297:Male; D015080:Mesna / Q000008:administration & dosage; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000401:mortality / Q000601:surgery; D012983:Soft Tissue Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D015996:Survival Rate
chemical_list: D005047:Etoposide; D004317:Doxorubicin; D015080:Mesna; D007069:Ifosfamide
vernacular_title: Weichteiltumoren: Indikation und Ergebnisse der Hyperthermie.